Skip to main content
Equibles

MORGAN STANLEY

Position in EXEL — Exelixis, Inc.

CIK 895421 NEW YORK, NY
Back to EXEL Full portfolio

Position in EXEL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$245,915,998
+$66,711,462 QoQ
Shares Held
4,519,684
+8.2% QoQ
Ownership
1.82%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#12
of 756 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 65% Shared 0% None 35%

Common Shares in EXEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. EXEL ranks #11 (1.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in EXEL

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $245,915,998 4,519,684
2026-03-31 $179,204,536 4,178,236
2025-12-31 $184,377,727 4,206,656
2025-09-30 $132,602,192 3,210,707
2025-06-30 $157,747,988 3,578,675
2025-03-31 $92,719,702 2,511,368
2024-12-31 $91,660,678 2,752,573
2024-09-30 $55,334,843 2,132,364
2024-06-30 $51,308,824 2,283,437
2024-03-31 $111,384,984 4,693,847
2023-12-31 $114,545,790 4,774,731
2023-09-30 $68,573,924 3,138,395
2023-06-30 $49,443,699 2,587,321
2023-03-31 $49,915,333 2,571,630
2022-12-31 $37,086,350 2,312,117
2022-09-30 $20,418,053 1,302,172
2022-06-30 $33,206,918 1,594,953
2022-03-31 $19,306,562 851,635
2021-12-31 $14,837,416 811,675
2021-09-30 $16,550,206 782,886
2021-06-30 $13,885,859 762,122
2021-03-31 $11,011,944 487,470
2020-12-31 $11,224,226 559,254
2020-09-30 $8,980,801 367,313
2020-06-30 $9,150,320 385,439
2020-03-31 $9,367,920 544,014